The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miR-223 is differentially expressed between the PBMCs and plasma in RA patients, suggesting that miR-223 could be a biological marker for RA diagnosis 95-98.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
Nakamachi, Y., Kawano, S., Takenokuchi, M., Nishimura, K., Sakai, Y., Chin, T., Saura, R., Kurosaka, M., & Kumagai, S. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24475 · Cited by 332
Research works printed but not linked: 42
- Bukhari, 2001, Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study, Arthritis Rheum, 44, 1248, 10.1002/1529-0131(200106)44:6<1248::AID-ART215>3.0.CO;2-8 · doi:10.1002/1529-0131(200106)44:6<1248::aid-art215>3.0.co;2-8
- Bukhari, 2003, Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study, Arthritis Rheum, 48, 46, 10.1002/art.10727 · DOI
- Raza, 2012, Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials, Ann Rheum Dis, 71, 1921, 10.1136/annrheumdis-2012-201893 · doi:10.1136/annrheumdis-2012-201893
- Nell, 2004, Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis, Rheumatology (Oxford), 43, 906, 10.1093/rheumatology/keh199 · DOI · Paper page
- Möttönen, 2002, Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis, Arthritis Rheum, 46, 894, 10.1002/art.10135 · doi:10.1002/art.10135
- Emery, 2012, Combination etanercept and methotrexate provides better disease control in very early (<=4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study, Ann Rheum Dis, 71, 989, 10.1136/annrheumdis-2011-201066 · DOI
- van der Linden, 2010, Long-term impact of delay in assessment of patients with early arthritis, Arthritis Rheum, 62, 3537, 10.1002/art.27692 · DOI · Paper page
- Aletaha, 2010, 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum, 62, 2569, 10.1002/art.27584 · DOI · Paper page
- Allaart, 2011, Treatment strategies in recent onset rheumatoid arthritis, Curr Opin Rheumatol, 23, 241, 10.1097/BOR.0b013e3283454111 · doi:10.1097/bor.0b013e3283454111
- Mjaavatten, 2010, The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis, Arthritis Res Ther, 12, R76, 10.1186/ar2995 · doi:10.1186/ar2995
- Filipowicz, 2008, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?, Nat Rev Genet, 9, 102, 10.1038/nrg2290 · DOI
- Furer, 2010, The role of microRNA in rheumatoid arthritis and other autoimmune diseases, Clin Immunol, 136, 1, 10.1016/j.clim.2010.02.005 · DOI
- Filková, 2012, MicroRNAs in rheumatoid arthritis: potential role in diagnosis and therapy, BioDrugs, 26, 131, 10.2165/11631480-000000000-00000 · DOI
- Stanczyk, 2008, Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, Arthritis Rheum, 58, 1001, 10.1002/art.23386 · DOI · Paper page
- Stanczyk, 2011, Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation, Arthritis Rheum, 63, 373, 10.1002/art.30115 · DOI · Paper page
- Kawano, 2011, miR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis, Ann Rheum Dis, 70, i88, 10.1136/ard.2010.138669 · DOI
- Kurowska-Stolarska, 2011, MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis, Proc Natl Acad Sci USA, 108, 11193, 10.1073/pnas.1019536108 · DOI · Paper page
- Niimoto, 2010, MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients, BMC Musculoskelet Disord, 11, 209, 10.1186/1471-2474-11-209 · DOI
- Pauley, 2008, Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients, Arthritis Res Ther, 10, R101, 10.1186/ar2493 · DOI · Paper page
- Li, 2010, Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis, Arthritis Res Ther, 12, R81, 10.1186/ar3006 · DOI · Paper page
- Fulci, 2010, miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis, Hum Immunol, 71, 206, 10.1016/j.humimm.2009.11.008 · DOI · Paper page
- Weber, 2010, The microRNA spectrum in 12 body fluids, Clin Chem, 56, 1733, 10.1373/clinchem.2010.147405 · DOI · Paper page
- Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci USA, 105, 10513, 10.1073/pnas.0804549105 · DOI · Paper page
- Chen, 2008, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res, 18, 997, 10.1038/cr.2008.282 · DOI · Paper page
- Murata, 2010, Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis, Arthritis Res Ther, 12, R86, 10.1186/ar3013 · DOI · Paper page
- Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, 31, 315, 10.1002/art.1780310302 · DOI · Paper page
- van der Heijde, 2012, Timing and magnitude of initial change in disease activity score 28 predicts the likelihood of achieving low disease activity at 1 year in rheumatoid arthritis patients treated with certolizumab pegol: a post-hoc analysis of the RAPID 1 trial, J Rheumatol, 39, 1326, 10.3899/jrheum.111171 · DOI
- Curtis, 2013, Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: Results from the TEAR Trial, J Rheumatol, 40, 527, 10.3899/jrheum.120715 · DOI
- Nakasa, 2008, Expression of microRNA-146 in rheumatoid arthritis synovial tissue, Arthritis Rheum, 58, 1284, 10.1002/art.23429 · DOI · Paper page
- Blüml, 2011, Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice, Arthritis Rheum, 63, 1281, 10.1002/art.30281 · DOI · Paper page
- Nakasa, 2011, The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis, Arthritis Rheum, 63, 1582, 10.1002/art.30321 · DOI · Paper page
- Li, 2012, Amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223, Arthritis Rheum, 64, 3240, 10.1002/art.34550 · DOI
- Vickers, 2011, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nat Cell Biol, 13, 423, 10.1038/ncb2210 · DOI · Paper page
- Arroyo, 2011, Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proc Natl Acad Sci USA, 108, 5003, 10.1073/pnas.1019055108 · DOI · Paper page
- Gilad, 2008, Serum microRNAs are promising novel biomarkers, PLoS One, 3, e3148, 10.1371/journal.pone.0003148 · DOI · Paper page
- Wang, 2010, Serum miR-146a and miR-223 as potential new biomarkers for sepsis, Biochem Biophys Res Commun, 394, 184, 10.1016/j.bbrc.2010.02.145 · DOI · Paper page
- Pigati, 2010, Selective release of microRNA species from normal and malignant mammary epithelial cells, PLoS One, 5, e13515, 10.1371/journal.pone.0013515 · DOI · Paper page
- Iguchi, 2010, Secretory microRNAs as a versatile communication tool, Commun Integr Biol, 3, 478, 10.4161/cib.3.5.12693 · DOI
- Sebastiani, 2011, Over-expression of miR-223 in T-lymphocytes of early rheumatoid arthritis patients, Clin Exp Rheumatol, 29, 1058
- McInnes, 2007, Cytokines in the pathogenesis of rheumatoid arthritis, Nat Rev Immunol, 7, 429, 10.1038/nri2094 · DOI · Paper page
- Ospelt, 2008, The role of resident synovial cells in destructive arthritis, Best Pract Res Clin Rheumatol, 22, 239, 10.1016/j.berh.2008.01.004 · DOI
- Raza, 2005, Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin, Arthritis Res Ther, 7, R784, 10.1186/ar1733 · DOI · Paper page
Cited by
Methodological challenges in utilizing mi RNA s as circulating biomarkers
Moldovan, L., Batte, K. E., Trgovcich, J., Wisler, J., Marsh, C. B., & Piper, M. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12236 · Cited by 436
Castro-Villegas, C., Pérez-Sánchez, C., Escudero, A., Filipescu, I., Verdu, M., Ruiz-Limón, P., Aguirre, M. A., Jiménez-Gomez, Y., Font, P., Rodriguez-Ariza, A., et al. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0555-z · Cited by 166
miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
Jiao, P., Wang, X.-P., Luoreng, Z.-M., Yang, J., Jia, L., Ma, Y., & Wei, D.-W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59876 · Cited by 151
Metadata
- Authors
- Filková, M., Aradi, B., Šenolt, L., Ospelt, C., Vettori, S., Mann, H., Filer, A., Raza, K., Buckley, C. D., Snow, M., Vencovský, J., Pavelka, K., Michel, B. A., Gay, R. E., Gay, S., & Jüngel, A.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 73
- Issue
- 10
- Pages
- 1898-1904
- ISSN
- 0003-4967
- Cited by
- 170
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc/3.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. https://app.cochat.ai/papers/10.1136/annrheumdis-2012-202815
- The paper
- Filková, M., Aradi, B., Šenolt, L., Ospelt, C., Vettori, S., Mann, H., Filer, A., Raza, K., Buckley, C. D., Snow, M., Vencovský, J., Pavelka, K., Michel, B. A., Gay, R. E., Gay, S., & Jüngel, A. (2014). Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2012-202815
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.